Filociclovir
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
JSmol) | |
| |
|
Filociclovir (cyclopropavir, MBX-400) is an
antiviral drug which was developed for the treatment of cytomegalovirus infection and also shows some activity against other double-stranded DNA viruses. It has reached Phase II human clinical trials.[1][2][3]